| A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia (NCT06672263) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2024-11-01 |
| DBS for Cognitive Deficits After Traumatic Brain Injury (NCT06818864) | Sunnybrook Health Sciences Centre | 2024-11-01 |
| Erector Spinae Plane Block with Dexmedetomidine and Bupivacain Versus Dexamethasone and Bupivacain for Postoperative Analgesia in Patients Undergoing Abdominal Surgeries (NCT06658418) | Loay Gamal | 2024-11-01 |
| A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants (NCT05358691) | Rutgers, The State University of New Jersey | 2024-11-01 |
| A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential (NCT06657105) | AstraZeneca | 2024-11-01 |
| Phase 1b Clinical Trial to Evaluate PEP and EUFLEXXA for Knee Osteoarthritis (KOA) (NCT06463132) | Rion Inc. | 2024-11-01 |
| Low-Dose Ketamine Infusion for Post-Operative Pain in Patients Undergoing Laparoscopic Cholecyctectomy (NCT06966596) | Fazaia Ruth Pfau Medical College | 2024-11-01 |
| Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL (NCT06641024) | Chongqing Precision Biotech Co., Ltd | 2024-11-01 |
| Evaluation of Nasal Elevator Versus Grayson's Nasal Stent with D-NAM Appliance on Nasolabial Esthetics in Bilateral Cleft Lip and Palate Infants (NCT06589453) | Cairo University | 2024-11-01 |
| Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma. (NCT06631391) | Sun Yat-sen University | 2024-11-01 |
| Comparative Study Between Photodynamic Therapy with LED Associated with Probiotics in the Treatment of Halitosis (NCT06583720) | University of Nove de Julho | 2024-11-01 |
| Effectiveness of Topical Vancomycin in Reducing Sternal Wound Infections Post-Cardiac Surgery (NCT06651268) | Liaquat National Hospital & Medical College | 2024-11-01 |
| Esophageal Replacement With a Decellularized Human Esophagus Graft (NCT06662370) | Assistance Publique - Hôpitaux de Paris | 2024-11-01 |
| A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway (NCT06614751) | Danatlas Pharmaceuticals Co., Ltd | 2024-11-01 |
| A First-In-Human Study of TAK-004 in Healthy Adults (NCT06236009) | Takeda | 2024-11-01 |
| A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant Tumors (NCT06649656) | Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd. | 2024-11-01 |
| SynKIR-310 for Relapsed/Refractory B-NHL (NCT06544265) | Verismo Therapeutics | 2024-11-01 |
| Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM (NCT06518551) | Omar Nadeem, MD | 2024-11-01 |
| Psilocybin for Treatment-Resistant Depression in Autism (NCT06731621) | Centre for Addiction and Mental Health | 2024-11-01 |
| The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study (NCT06770296) | The First Affiliated Hospital with Nanjing Medical University | 2024-11-01 |
| Deep Brain Stimulation for Refractory PTSD (NCT06705296) | Sunnybrook Health Sciences Centre | 2024-11-01 |
| TAP Block , Intrathecal Morphine Or Their Combination For Post Operative Analgesia Following TAH (NCT06882369) | Minia University | 2024-11-01 |
| Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia (NCT06684509) | Assiut University | 2024-11-01 |
| Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948 (NCT06691828) | Nurix Therapeutics, Inc. | 2024-11-01 |
| Drug-Drug Interaction (DDI) Study for TQB3616 (NCT06662773) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-11-01 |
| A Phase I Study of CDX-622 (NCT06650761) | Celldex Therapeutics | 2024-11-01 |
| Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors (NCT04890093) | National Cancer Institute (NCI) | 2024-10-31 |
| Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201 (NCT06341647) | GC Cell Corporation | 2024-10-31 |
| Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas (NCT06217536) | University of California, San Francisco | 2024-10-31 |
| Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin (NCT06576037) | M.D. Anderson Cancer Center | 2024-10-31 |
| Safety and Tolerability of AZD5148 in Japanese Participants (NCT06639997) | AstraZeneca | 2024-10-31 |
| In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted) (NCT07119073) | Cingulate Therapeutics | 2024-10-31 |
| PK and PD of YG1699 in CKD Patients With Diabetes (NCT06648876) | RenJi Hospital | 2024-10-31 |
| RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies (NCT06732492) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-10-31 |
| Mifepristone vs Misoprostol (NCT06502158) | Montefiore Medical Center | 2024-10-31 |
| A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization (NCT06547112) | Washington University School of Medicine | 2024-10-31 |
| AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer (NCT05826015) | Washington University School of Medicine | 2024-10-31 |
| A Study of DM005 in Patients With Advanced Solid Tumors (NCT06515990) | Doma Biopharmaceutical（Suzhou）Co., Ltd. | 2024-10-31 |
| 89Zr-olaratumab Dosimetry in Participants With PDGFR Alpha Positive Solid Tumours and Soft Tissue Sarcoma (NCT06537596) | Telix Pharmaceuticals (Innovations) Pty Ltd | 2024-10-31 |
| A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants (NCT06655870) | ModernaTX, Inc. | 2024-10-31 |
| A Phase I Clinical Trial of JH013 Injection (NCT06633055) | Biotech Pharmaceutical Co., Ltd. | 2024-10-31 |
| A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors (NCT06594874) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2024-10-31 |
| SAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew) (NCT06461286) | PYC Therapeutics | 2024-10-31 |
| Efficacy and Safety of Topical Cyclosporine 0.05% and Lifitgrast on the Ocular Surface Symptom After Photorefractive Keratectomy in Feiz Hospital, Isfahan, 2024 (NCT06624384) | Mohsen Pourazizi | 2024-10-30 |
| Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC) (NCT07670858) | Feldan Therapeutics | 2024-10-30 |
| A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations (NCT06644768) | Daiichi Sankyo | 2024-10-30 |
| REscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2 (NCT06607367) | Melbourne Health | 2024-10-30 |
| Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus (NCT06691152) | The Children's Hospital of Zhejiang University School of Medicine | 2024-10-30 |
| A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects (NCT06670209) | Gan and Lee Pharmaceuticals, USA | 2024-10-30 |
| Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia (NCT06451770) | Verve Therapeutics, Inc. | 2024-10-30 |
| A Study of the ILB-3101 in Patients with Advanced Solid Tumors (NCT06426680) | Innolake Biopharm | 2024-10-30 |
| Reirradiation Dose Escalation in Thoracic Cancers (NCT06558175) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2024-10-30 |
| A Study of HS-20124 in Patients with Advanced Solid Tumors (NCT06763159) | Hansoh BioMedical R&D Company | 2024-10-30 |
| A Study of ZW191 in Participants With Solid Tumors (NCT06555744) | Zymeworks BC Inc. | 2024-10-30 |
| A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects (NCT06621316) | Shandong Suncadia Medicine Co., Ltd. | 2024-10-30 |
| A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men (NCT06631430) | Boehringer Ingelheim | 2024-10-30 |
| Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding (NCT07169214) | ScinnoHub Pharmaceutical Co., Ltd. | 2024-10-30 |
| Clinical Trial of Zuoqing SAN in Treating Ulcerative Colitis (NCT06667934) | The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine | 2024-10-30 |
| Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors (NCT06819215) | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | 2024-10-30 |
| A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma (NCT06630806) | Sanofi | 2024-10-30 |
| A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors (NCT06609187) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-10-30 |
| NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique (NCT06610071) | The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | 2024-10-30 |
| A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo (NCT06602232) | Dren Bio | 2024-10-30 |
| Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors (NCT06541262) | Milton S. Hershey Medical Center | 2024-10-30 |
| Study to Assess the Effect of a CYP3A Weak Inducer Rufinamide on Quizartinib Pharmacokinetics in Healthy Subjects (NCT06740825) | Daiichi Sankyo | 2024-10-29 |
| An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors (NCT06238401) | Hangzhou Adcoris Biopharmacy Co., Ltd | 2024-10-29 |
| A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian Participants (NCT06673238) | AbbVie | 2024-10-29 |
| Phase I Safety Study of Inhaled N-IP-00001 to Determine Tolerability and Safety in Healthy Volunteers. (NCT06662019) | NeoTrials Pty Ltd | 2024-10-29 |
| Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors (NCT06625775) | TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | 2024-10-29 |
| Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Supplemental Open-Label Arm (NCT06587217) | University of Michigan | 2024-10-29 |
| A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) (NCT06657768) | Eli Lilly and Company | 2024-10-29 |
| Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS Glargine (G), United States (US)-Lantus®, and European Union (EU)-Lantus® (NCT06627478) | Xentria, Inc. | 2024-10-29 |
| Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer (NCT06546969) | University of Maryland, Baltimore | 2024-10-29 |
| Clinical Trial of Efepoetin Alfa in Healthy Subjects (NCT06490939) | Genexine, Inc. | 2024-10-29 |
| Clinical Application Comparison of Two Femtosecond Laser Systems (NCT06754358) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-10-29 |
| A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults (NCT06646042) | Pfizer | 2024-10-28 |
| RCI001 Eye Drops 0.25% in Healthy Adult Male Participants (NCT07640867) | Rudacure | 2024-10-28 |
| A Pilot Study of Microbiota Transplant With Antibiotic Preconditioning and Fiber Supplementation in Pulmonary Arterial Hypertension (GUT RESTORE-PAH) (NCT06481852) | University of Minnesota | 2024-10-28 |
| A Study of [14C]-LY3866288 in Healthy Participants (NCT06644378) | Eli Lilly and Company | 2024-10-28 |
| CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas (NCT07168486) | University of Maryland, Baltimore | 2024-10-28 |
| PK Study of Gefurulimab SC in Healthy Chinese Adult Participants (NCT06677138) | Alexion Pharmaceuticals, Inc. | 2024-10-28 |
| Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer (NCT06040970) | Icahn School of Medicine at Mount Sinai | 2024-10-28 |
| Effects of Low-intensity Transcranial Magnetic Stimulation on Major Depressive Disorder, and on 5-hydroxyindoleacetic Acid and Brain-derived Neurotrophic Factor Levels (NCT06667180) | Universidad de Guanajuato | 2024-10-28 |
| Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects (NCT07134478) | Haisco Pharmaceutical Group Co., Ltd. | 2024-10-28 |
| Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinomas (NCT06654297) | West China Hospital | 2024-10-27 |
| Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC (NCT06193486) | H. Lee Moffitt Cancer Center and Research Institute | 2024-10-26 |
| Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults (NCT06644404) | Daewoong Pharmaceutical Co. LTD. | 2024-10-26 |
| Relative Bioavailability of Two Orally Administered CBD Formulations in Healthy Male Adults (NCT06574100) | University of Saskatchewan | 2024-10-26 |
| A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer (NCT06638307) | Stemline Therapeutics, Inc. | 2024-10-25 |
| Dapagliflozin in Mangement of Pulmonary Hypertension Patients (NCT06612086) | Assiut University | 2024-10-25 |
| A Phase Ib Study of RC1416 Injection (NCT06911866) | Nanjing RegeneCore Biotech Co., Ltd. | 2024-10-25 |
| An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia (NCT06655519) | Peking University People's Hospital | 2024-10-25 |
| A Study of TeriQ Patch in Healthy Adult Female Participants (NCT06644040) | QuadMedicine | 2024-10-25 |
| Integrative Breathwork Intervention for Chronic Pain (NCT06546956) | University of Florida | 2024-10-24 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors (NCT06656390) | Shanghai Allink Biotherapeutics Co., Ltd. | 2024-10-24 |
| Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation (NCT07084311) | n-Lorem Foundation | 2024-10-24 |
| Bioequivalence Study Between UI009 and UIC202005 in Healthy Subjects (NCT07110740) | Korea United Pharm. Inc. | 2024-10-24 |
| A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate (NCT06772246) | Daiichi Sankyo | 2024-10-24 |
| Study of DM5167 in Patients With Advanced Solid Tumors (NCT07101601) | DIGMBIO | 2024-10-24 |
| A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of KP-001 (NCT06619054) | Kaken Pharmaceutical | 2024-10-24 |